Primary: To evaluate the efficacy of immersive virtual reality (VR) in reducing neuropathic pain (NP) in individuals with spinal cord injury (SCI).
Secondary: To assess the impact of immersive VR on depersonalization symptoms in the SCI population.
Design: Double-blind, randomized controlled trial.